Matches in Wikidata for { <http://www.wikidata.org/entity/Q90546621> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q90546621 description "article scientifique publié en 2019" @default.
- Q90546621 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90546621 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90546621 description "scientific article published on 07 October 2019" @default.
- Q90546621 description "wetenschappelijk artikel" @default.
- Q90546621 description "наукова стаття, опублікована 7 жовтня 2019" @default.
- Q90546621 description "գիտական հոդված հրատարակված 2019 թվականի հոկտեմբերի 7-ին" @default.
- Q90546621 name "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 name "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 type Item @default.
- Q90546621 label "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 label "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 prefLabel "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 prefLabel "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 P1433 Q90546621-17543BA6-D195-4267-89E9-F7BBD687D560 @default.
- Q90546621 P1476 Q90546621-6052CF4A-EA1C-4698-ACB2-3512B2018005 @default.
- Q90546621 P2093 Q90546621-0C666BAB-B047-4E82-8A44-7DC9D050CE09 @default.
- Q90546621 P2093 Q90546621-1DE02B6D-B9EA-4D78-9051-F7DBEC5FBD45 @default.
- Q90546621 P2093 Q90546621-805FE830-74EE-4CBB-A451-EC356ED8FD3C @default.
- Q90546621 P2093 Q90546621-9AA56959-C399-4209-9185-B1D17E64B761 @default.
- Q90546621 P2093 Q90546621-A52547A7-75C4-42C1-B972-5425CFF02552 @default.
- Q90546621 P304 Q90546621-B75D6E9E-A146-44CC-8DC3-4F8E54C3417E @default.
- Q90546621 P31 Q90546621-24B362A5-386C-40CA-B956-1013DEB6AFAD @default.
- Q90546621 P31 Q90546621-26964ea7-40ab-4c8b-9330-6d6d0bac04d7 @default.
- Q90546621 P356 Q90546621-47E3D255-577E-4015-901F-02DE4D22A8EF @default.
- Q90546621 P433 Q90546621-2BB301D1-AE14-4B9C-AB24-1E067A14CE3B @default.
- Q90546621 P478 Q90546621-F0B26A49-E161-4160-9C80-64AA6E00785F @default.
- Q90546621 P50 Q90546621-0C259882-C14E-4CCA-85E6-15C8C6005875 @default.
- Q90546621 P50 Q90546621-A7DC7ECF-A0D2-4F5B-B237-BE35CB0B6795 @default.
- Q90546621 P50 Q90546621-C4377FB6-605A-4C33-A1F9-7182FC2278AE @default.
- Q90546621 P577 Q90546621-8F052C0F-5F49-44CD-BF58-B794187CFF42 @default.
- Q90546621 P698 Q90546621-984F078B-7E93-40F5-B305-3D050B003733 @default.
- Q90546621 P921 Q90546621-AD9771C8-91F8-48FE-9193-9DDA05EA3C35 @default.
- Q90546621 P921 Q90546621-FBF919CC-DD13-452E-9243-6FF7FAA4D06A @default.
- Q90546621 P356 FON-2019-0287 @default.
- Q90546621 P698 31588789 @default.
- Q90546621 P1433 Q2781597 @default.
- Q90546621 P1476 "Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials" @default.
- Q90546621 P2093 "Alessandro Cucchetti" @default.
- Q90546621 P2093 "Calogero Cammà" @default.
- Q90546621 P2093 "Giacomo Emanuele Maria Rizzo" @default.
- Q90546621 P2093 "Giorgio Ercolani" @default.
- Q90546621 P2093 "Philip Johnson" @default.
- Q90546621 P304 "3411-3422" @default.
- Q90546621 P31 Q13442814 @default.
- Q90546621 P31 Q7318358 @default.
- Q90546621 P356 "10.2217/FON-2019-0287" @default.
- Q90546621 P433 "29" @default.
- Q90546621 P478 "15" @default.
- Q90546621 P50 Q38804193 @default.
- Q90546621 P50 Q42838004 @default.
- Q90546621 P50 Q89209074 @default.
- Q90546621 P577 "2019-10-07T00:00:00Z" @default.
- Q90546621 P698 "31588789" @default.
- Q90546621 P921 Q1148337 @default.
- Q90546621 P921 Q42824827 @default.